Post

New research · Ophthalmology
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2d
Cross-sectionalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2026

Body Composition and Body Mass Index Show Comparable Associations with Adalimumab Exposure and Immunogenicity in Noninfectious Uveitis.

Francesco Pichi, Rauda Shehab, Piergiorgio Neri
Read paper
OphthalmologyCross-sectional

Higher body mass index is associated with lower adalimumab drug levels in uveitis patients.

Body Composition and Body Mass Index Show Comparable Associations with Adalimumab Exposure and Immunogenicity in Noninfectious Uveitis.

Francesco Pichi … Piergiorgio Neri
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2026
Purpose

To evaluate whether bioimpedance-derived body composition parameters are associated with adalimumab exposure and immunogenicity in noninfectious uveitis (noninfectious uveitis) and whether they provide information complementary to body mass index (BMI).

Methods

Forty-five patients with noninfectious uveitis receiving adalimumab monotherapy (40 mg every 2 weeks) for at least 12 months were enrolled in this single-center cross-sectional study.

Results
r = -0.51
higher BMI tends to go with lower adalimumab drug levels in blood
More results

In separate multivariable models adjusted for age and sex, each adiposity measure was independently associated with trough concentrations (adjusted R 2 0.18-0.25).

ROC analysis showed comparable discrimination of low drug exposure for BMI (area under the curve [AUC] 0.69) and body composition metrics (AUC 0.70-0.74; DeLong P > 0.5).

More results

BMI showed the strongest correlation with anti-adalimumab antibodies levels ( r = 0.58, P < 0.0001).

“
Conclusion · 1 of 3

Bioimpedance-derived adiposity measures and BMI showed similar associations with adalimumab exposure in noninfectious uveitis.

Conclusion · 2 of 3

Body composition may offer complementary biological context for interpreting pharmacokinetic variability and immunogenicity.

Conclusion · 3 of 3

Future studies are warranted to determine whether body composition data improve therapeutic drug monitoring in uveitis.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment